» Articles » PMID: 22511630

A Connective Tissue Growth Factor Signaling Receptor in Corneal Fibroblasts

Overview
Specialty Ophthalmology
Date 2012 Apr 19
PMID 22511630
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To biochemically characterize the receptor for connective tissue growth factor (CTGF) of human corneal fibroblasts (HCF).

Methods: Radiolabeled recombinant human CTGF was used to determine the specificity and time course of binding to low-passage cultures of HCF. The affinity and number of receptors present were calculated by Scatchard and best-fit analyses. In vitro immunoprecipitation assays with radiolabeled CTGF and soluble mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF-2-R) alone, or with CTGF-related growth factors were conducted. Additionally, (125)I-CTGF-binding and CTGF-stimulated proliferation were measured in cultures of M6P/IGF-2-R knockout fibroblasts.

Results: Binding of (125)I-CTGF to fibroblast cultures was significantly displaced by CTGF, but not by related growth factors. Scatchard plot analysis indicated the presence of both a high-affinity, low-abundance binding site, and a low-affinity, high-abundance binding site; whereas, the best-fit analysis suggests a single high-affinity, low-abundance binding site. A 280 kDa complex containing cross-linked (125)I-CTGF was immunoprecipitated by antibodies to CTGF or M6P/IGF-2-R. M6P/IGF-2-R knockout cells have a reduced proliferative response to TGF-β, and don't proliferate at all in response to CTGF.

Conclusions: CTGF binds to the M6P/IGF-2-R with high affinity, and the M6P/IGF-2-R is required for CTGF-stimulated proliferation in fibroblasts. These observations suggest that the M6P/IGF-2-R may be a new antifibrotic target.

Citing Articles

Characterization of the Ocular Phenotype in a Col4a3 Knockout Mouse Model of Alport Syndrome.

Belamkar A, Luo Q, Mahajan N, Abhyankar S, Jones B, Sodhi R Invest Ophthalmol Vis Sci. 2024; 65(14):29.

PMID: 39680378 PMC: 11654772. DOI: 10.1167/iovs.65.14.29.


WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD.

Christopoulou M, Aletras A, Papakonstantinou E, Stolz D, Skandalis S Int J Mol Sci. 2024; 25(18).

PMID: 39337534 PMC: 11432718. DOI: 10.3390/ijms251810049.


Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL).

Peeney D, Gurung S, Rich J, Coates-Park S, Liu Y, Toor J J Proteome Res. 2024; 23(10):4715-4728.

PMID: 39238192 PMC: 11460327. DOI: 10.1021/acs.jproteome.4c00606.


An overview of CCN4 (WISP1) role in human diseases.

Singh K, Oladipupo S J Transl Med. 2024; 22(1):601.

PMID: 38937782 PMC: 11212430. DOI: 10.1186/s12967-024-05364-8.


Connective tissue growth factor: Role in trabecular meshwork remodeling and intraocular pressure lowering.

Hassan M, Razali N, Bakar A, Abu Hanipah N, Agarwal R Exp Biol Med (Maywood). 2023; 248(16):1425-1436.

PMID: 37873757 PMC: 10657592. DOI: 10.1177/15353702231199466.


References
1.
Albrecht C, von der Kammer H, Mayhaus M, Klaudiny J, Schweizer M, Nitsch R . Muscarinic acetylcholine receptors induce the expression of the immediate early growth regulatory gene CYR61. J Biol Chem. 2000; 275(37):28929-36. DOI: 10.1074/jbc.M003053200. View

2.
Schlessinger J, Lax I, Lemmon M . Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?. Cell. 1995; 83(3):357-60. DOI: 10.1016/0092-8674(95)90112-4. View

3.
Kornfeld S . Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem. 1992; 61:307-30. DOI: 10.1146/annurev.bi.61.070192.001515. View

4.
Valenzano K, Remmler J, Lobel P . Soluble insulin-like growth factor II/mannose 6-phosphate receptor carries multiple high molecular weight forms of insulin-like growth factor II in fetal bovine serum. J Biol Chem. 1995; 270(27):16441-8. DOI: 10.1074/jbc.270.27.16441. View

5.
Hurvitz J, Suwairi W, Van Hul W, El-Shanti H, Superti-Furga A, Roudier J . Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet. 1999; 23(1):94-8. DOI: 10.1038/12699. View